Paradigm Capital Management Establishes 5.2% Passive Stake in Integra LifeSciences Holdings Corp

Paradigm Capital Management, Inc., an investment adviser based in Albany, NY, has filed a Schedule 13G disclosing a new passive ownership stake in Integra LifeSciences Holdings Corp (IART). As of the event date on March 31, 2026, the firm reported beneficial ownership of 4,012,698 shares of common stock, representing 5.2% of the company's outstanding shares. The filing indicates that Paradigm Capital Management has sole voting and dispositive power over the entirety of these shares. The securities are held on behalf of various advisory clients in the ordinary course of business, with no intent to influence or change the control of the issuer. This filing marks a significant increase from a previous 0% position, crossing the 5% regulatory threshold for reporting. The document was signed by Richard Gimon, Chief Compliance Officer, on May 15, 2026.